BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35875108)

  • 1. Dynamic Characteristics and Predictive Capability of Tumor Voxel Dose-Response Assessed Using
    Chen S; Qin A; Yan D
    Front Oncol; 2022; 12():876861. PubMed ID: 35875108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of uncertainties in quantitative
    Chen S; Yan D; Qin A; Maniawski P; Krauss DJ; Wilson GD
    Med Phys; 2020 Nov; 47(11):5681-5692. PubMed ID: 32966627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Voxel Dose-Response Matrix and Dose Prescription Function Derived Using
    Yan D; Chen S; Krauss DJ; Chen PY; Chinnaiyan P; Wilson GD
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):207-218. PubMed ID: 30684661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter/intra-tumoral dose response variations assessed using FDG-PET/CT feedback images: Impact on tumor control and treatment dose prescription.
    Yan D; Chen S; Krauss DJ; Deraniyagala R; Chen P; Ye H; Wilson G
    Radiother Oncol; 2021 Jan; 154():235-242. PubMed ID: 33035624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.
    Yan A; Hanna A; Wilson TG; Deraniyagala R; Krauss DJ; Grzywacz VP; Yan D; Wilson GD
    Radiother Oncol; 2021 Nov; 164():196-201. PubMed ID: 34619238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo spatial correlation between (18)F-BPA and (18)F-FDG uptakes in head and neck cancer.
    Kobayashi K; Kurihara H; Watanabe Y; Murakami N; Inaba K; Nakamura S; Wakita A; Okamoto H; Umezawa R; Takahashi K; Igaki H; Ito Y; Yoshimoto S; Shigematsu N; Itami J
    Appl Radiat Isot; 2016 Sep; 115():138-146. PubMed ID: 27372808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.
    Lee E; Zeng J; Miyaoka RS; Saini J; Kinahan PE; Sandison GA; Wong T; Vesselle HJ; Rengan R; Bowen SR
    Med Phys; 2017 Jul; 44(7):3418-3429. PubMed ID: 28453861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
    Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
    Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of elastix-based propagated align algorithm for VOI- and voxel-based analysis of longitudinal (18)F-FDG PET/CT data from patients with non-small cell lung cancer (NSCLC).
    Kerner GS; Fischer A; Koole MJ; Pruim J; Groen HJ
    EJNMMI Res; 2015; 5():15. PubMed ID: 25853021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.
    Differding S; Sterpin E; Janssens G; Hanin FX; Lee JA; Grégoire V
    Acta Oncol; 2016; 55(2):217-25. PubMed ID: 26079436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.
    Huang W; Zhou T; Ma L; Sun H; Gong H; Wang J; Yu J; Li B
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1628-35. PubMed ID: 21617977
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Elhalawani H; Cardenas CE; Volpe S; Barua S; Stieb S; Rock CB; Lin T; Yang P; Wu H; Zaveri J; Elgohari B; Abdallah LE; Jethanandani A; Mohamed ASR; Court LE; Hutcheson KA; Brandon Gunn G; Rosenthal DI; Frank SJ; Garden AS; Rao A; Fuller CD
    Clin Transl Radiat Oncol; 2021 Jul; 29():93-101. PubMed ID: 34195391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of maximum likelihood and conventional PET scatter scaling methods for
    Bal H; Kiser JW; Conti M; Bowen SL
    Med Phys; 2021 Aug; 48(8):4218-4228. PubMed ID: 34013586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.
    Prieto E; Martí-Climent JM; Domínguez-Prado I; Garrastachu P; Díez-Valle R; Tejada S; Aristu JJ; Peñuelas I; Arbizu J
    J Nucl Med; 2011 Jun; 52(6):865-72. PubMed ID: 21571807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
    Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
    J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changes.
    Choi H; Yoon HJ; Kim TS; Oh JH; Kim DY; Kim SK
    Nucl Med Commun; 2013 Dec; 34(12):1166-73. PubMed ID: 24128896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
    Banks TI; von Eyben R; Hristov D; Kidd EA
    Cancer Med; 2018 Aug; 7(8):3642-3651. PubMed ID: 29963760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial.
    Berwouts D; Olteanu LA; Duprez F; Vercauteren T; De Gersem W; De Neve W; Van de Wiele C; Madani I
    Radiother Oncol; 2013 Jun; 107(3):310-6. PubMed ID: 23647760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
    J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.